2011
DOI: 10.4155/bio.11.135
|View full text |Cite
|
Sign up to set email alerts
|

Recommendations On: Internal Standard Criteria, Stability, Incurred Sample Reanalysis and Recent 483s by the Global CRO Council for Bioanalysis

Abstract: "The Global CRO Council (GCC) for Bioanalysis was formed in an effort to bring together many CRO leaders to openly discuss bioanalysis and the regulatory challenges unique to the outsourcing industry"

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
46
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
4

Relationship

3
7

Authors

Journals

citations
Cited by 78 publications
(46 citation statements)
references
References 8 publications
0
46
0
Order By: Relevance
“…The chosen IS should resemble the analyte of interest during the sample preparation and analysis [28]. It should perfectly track the analyte and improves both accuracy and precision of the assay.…”
Section: Selection Of Internal Standardmentioning
confidence: 99%
“…The chosen IS should resemble the analyte of interest during the sample preparation and analysis [28]. It should perfectly track the analyte and improves both accuracy and precision of the assay.…”
Section: Selection Of Internal Standardmentioning
confidence: 99%
“…The Global CRO Council for bioana lysis [19] has started an ini tiative to collect CRO data already available or in progress on matrix stability for coformu lated and coadministered drugs. An article was published to that effect, providing preliminary results of a survey distributed to all Global CRO Council members and demonstrating the gen eral lack of an impact on stability caused by the presence of such drugs [20].…”
Section: Effect Of Anticoagulant Counterionsmentioning
confidence: 99%
“…More detailed information is available on its website [101]. QC; the use of a predefined criteria for samples employed for system conditioning and system suitability; the stability of compounds stated as light sensitive by suppliers; the approach for performing whole-blood stability; findings regarding IS variability; carryover and reporting of validation evaluations [12,[30][31][32][33][34]104]. An FDA untitled letter issued following FDA inspections of the bioanalytical facility of Cetero Research reporting dates/times falsifications, manipulation of samples and lack of documentation regarding system equilibration was discussed by Roger Hayes (Vice President and General Manager of Laboratory Sciences, MPI Research, USA).…”
Section: Appendix: 6th Wrib Conference Reportmentioning
confidence: 99%